Release Date: 16/08/19 14:01 Summary: Change of Principal Place of Business Price Sensitive: No Download Document 165.91KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%